Inexium /01479302/


Indications and Reactions:

Role Indications Reactions
Secondary
Product Used For Unknown Indication 67.4%
Drug Use For Unknown Indication 6.2%
Pain 4.7%
Diabetes Mellitus 2.7%
Angina Pectoris 2.3%
Cardiac Failure 2.3%
Renal Transplant 1.9%
Insomnia 1.6%
Type 2 Diabetes Mellitus 1.6%
Gastrooesophageal Reflux Disease 1.2%
Lung Neoplasm Malignant 1.2%
Antibiotic Therapy 0.8%
Aspergillus Infection 0.8%
Cerebrovascular Accident 0.8%
Coronary Angioplasty 0.8%
Fusarium Infection 0.8%
Gastrointestinal Haemorrhage 0.8%
Hypertension 0.8%
Hyperthermia 0.8%
Hypokalaemia 0.8%
Anaemia Haemolytic Autoimmune 13.8%
Haematoma 10.3%
Thrombocytopenia 10.3%
Renal Impairment 6.9%
Transaminases Increased 6.9%
Drug Ineffective 3.4%
Hallucination 3.4%
Hepatitis 3.4%
Interstitial Lung Disease 3.4%
Liver Injury 3.4%
Malaise 3.4%
Pancreatitis Acute 3.4%
Pancytopenia 3.4%
Pleural Effusion 3.4%
Pruritus 3.4%
Rash 3.4%
Rash Erythematous 3.4%
Red Blood Cell Abnormality 3.4%
Renal Failure 3.4%
Rhabdomyolysis 3.4%
Concomitant
Product Used For Unknown Indication 40.6%
Drug Use For Unknown Indication 12.7%
Hypertension 7.6%
Type 2 Diabetes Mellitus 4.7%
Pain 4.4%
Prophylaxis 4.1%
Plasma Cell Myeloma 3.9%
Multiple Myeloma 3.3%
Anaemia 2.7%
Prophylaxis Against Transplant Rejection 2.6%
Diabetes Mellitus 2.0%
Mantle Cell Lymphoma 1.8%
Depression 1.5%
Immunosuppression 1.5%
Renal Transplant 1.4%
Anxiety 1.1%
Atrial Fibrillation 1.1%
Hypercholesterolaemia 1.1%
Rheumatoid Arthritis 1.1%
Back Pain 0.9%
Thrombocytopenia 14.3%
Somnolence 9.5%
Vomiting 8.3%
Hypoglycaemia 7.1%
Renal Failure Acute 6.0%
Malaise 4.8%
Pyrexia 4.8%
Urinary Retention 4.8%
Wound 4.8%
Cerebellar Syndrome 3.6%
Orthostatic Hypotension 3.6%
Pancytopenia 3.6%
Renal Impairment 3.6%
Respiratory Disorder 3.6%
Respiratory Distress 3.6%
Shock 3.6%
Weight Decreased 3.6%
Agranulocytosis 2.4%
Escherichia Infection 2.4%
Hepatitis 2.4%

Drug Data